Alcohol Use Disorder study: InTEGRA vs MET/CBT
Official title Integrated Treatment for Enhancing Growth in Recovery During Adolescence
ClinicalTrials.gov ID: NCT06395467
What this study is testing
- What it's testing
- The study compares InTEGRA, which mixes 12‑step help with motivational and cognitive‑behavioral therapy, to standard therapy alone. It looks at whether InTEGRA leads to more 12‑step attendance, more abstinence, and fewer negative consequences over a year.
- Who it's for
- Teenagers aged 14 to 21 who use alcohol or other drugs and are seeking treatment.
- What's involved
- Participants receive one of two active therapy programs, attend regular counseling sessions, and may be asked to join 12‑step meetings. They also complete questionnaires and follow‑up assessments.
- Time commitment
- The program lasts about 12 weeks of treatment, followed by yearly check‑ins for up to one year after the last session.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 21
You may be able to join if
- 14-21 years old
- SUD based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
- able to read and comprehend English at a 5th-grade level
- residence in Eastern time zone states (Connecticut, Delaware, Florida, Georgia, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New...
- any AOD use in the past 90 days (or in the 90 days prior to being in a controlled environment)
You likely can't join if
- suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or others, or a history of self-injurious behavior occurring in past 30 days
- lifetime diagnosis of schizophrenia
- current health condition (i.e., medical, psychiatric) that compromises participant's ability to attend outpatient treatment
- demonstrate inability or unwillingness to identify a "locator" who could be contacted in case participant becomes lost to follow-up; or
- youth attending another SUD treatment program or receiving psychotherapy that could conflict with study treatments.
See the full eligibility criteria
- 14-21 years old
- SUD based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
- able to read and comprehend English at a 5th-grade level
- residence in Eastern time zone states (Connecticut, Delaware, Florida, Georgia, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode...
- any AOD use in the past 90 days (or in the 90 days prior to being in a controlled environment)
- meet patient placement criteria for level I (outpatient) treatment
- participant and a family member/guardian responsible for providing collateral information (for those \<18 years) agree to sign Institutional Review Board (IRB)-approved consent
- participant and family member responsible for providing collateral information who could be contacted in case the subject became lost to follow-up.
- suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or others, or a history of self-injurious behavior occurring in past 30 days
- lifetime diagnosis of schizophrenia
- current health condition (i.e., medical, psychiatric) that compromises participant's ability to attend outpatient treatment
- demonstrate inability or unwillingness to identify a "locator" who could be contacted in case participant becomes lost to follow-up; or
- youth attending another SUD treatment program or receiving psychotherapy that could conflict with study treatments.
The study team makes the final eligibility decision.
Where it is enrolling
- Farmington, Connecticut, United States
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Farmington, Connecticut, United States; Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.